Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

Mel Krajden; Darrel Cook; Amanda Yu; Ron Chow; Qiang Su; Wendy Mei; Shelly McNeil; Deborah Money; Marc Dionne; Joel Palefsky; Karuna Karunakaran; Tobias Kollmann; Gina Ogilvie; Martin Petric; Simon Dobson

doi:10.1016/j.vaccine.2013.09.007

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

Mel Krajden, Darrel Cook, Amanda Yu, Ron Chow, Qiang Su, Wendy Mei, Shelly McNeil, Deborah Money, Marc Dionne, Joel Palefsky, Karuna Karunakaran, Tobias Kollmann, Gina Ogilvie, Martin Petric, Simon Dobson

Decision Sciences

科研成果: 期刊稿件 › 文章 › 同行评审

33 引用（Scopus）

源语言	英语
页（从-至）	624-630
页数	7
期刊	Vaccine
卷	32
期	5
DOI	https://doi.org/10.1016/j.vaccine.2013.09.007
出版状态	已出版 - 1月 23 2014

!!!ASJC Scopus Subject Areas

分子药学
一般免疫学和微生物学
一般兽医学
公共卫生、环境和职业健康
传染病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.vaccine.2013.09.007

其它文件与链接

引用此

Krajden, M., Cook, D., Yu, A., Chow, R., Su, Q., Mei, W., McNeil, S., Money, D., Dionne, M., Palefsky, J., Karunakaran, K., Kollmann, T., Ogilvie, G., Petric, M., & Dobson, S. (2014). Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine, 32(5), 624-630. https://doi.org/10.1016/j.vaccine.2013.09.007

Krajden, M, Cook, D, Yu, A, Chow, R, Su, Q, Mei, W, McNeil, S, Money, D, Dionne, M, Palefsky, J, Karunakaran, K, Kollmann, T, Ogilvie, G, Petric, M & Dobson, S 2014, 'Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial', Vaccine, 卷 32, 号码 5, 页码 624-630. https://doi.org/10.1016/j.vaccine.2013.09.007

@article{3489255c75d042079f9e92ef7acdc285,

title = "Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial",

author = "Mel Krajden and Darrel Cook and Amanda Yu and Ron Chow and Qiang Su and Wendy Mei and Shelly McNeil and Deborah Money and Marc Dionne and Joel Palefsky and Karuna Karunakaran and Tobias Kollmann and Gina Ogilvie and Martin Petric and Simon Dobson",

note = "Funding Information: This work was supported by grants from the Michael Smith Foundation for Health Research ( PJ-HPV-002078 ) and the Merck Investigator-Initiated Studies Program (IIS # 39229 ). The study sponsors had no role in the study design, collection, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication. ",

year = "2014",

month = jan,

day = "23",

doi = "10.1016/j.vaccine.2013.09.007",

language = "English",

volume = "32",

pages = "624--630",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

AU - Krajden, Mel

AU - Cook, Darrel

AU - Yu, Amanda

AU - Chow, Ron

AU - Su, Qiang

AU - Mei, Wendy

AU - McNeil, Shelly

AU - Money, Deborah

AU - Dionne, Marc

AU - Palefsky, Joel

AU - Karunakaran, Karuna

AU - Kollmann, Tobias

AU - Ogilvie, Gina

AU - Petric, Martin

AU - Dobson, Simon

N1 - Funding Information: This work was supported by grants from the Michael Smith Foundation for Health Research ( PJ-HPV-002078 ) and the Merck Investigator-Initiated Studies Program (IIS # 39229 ). The study sponsors had no role in the study design, collection, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication.

PY - 2014/1/23

Y1 - 2014/1/23

UR - http://www.scopus.com/inward/record.url?scp=84891664236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891664236&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.09.007

DO - 10.1016/j.vaccine.2013.09.007

M3 - Article

C2 - 24055350

AN - SCOPUS:84891664236

SN - 0264-410X

VL - 32

SP - 624

EP - 630

JO - Vaccine

JF - Vaccine

IS - 5

ER -

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此